FAIR VALUE MEASUREMENTS AND DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

9 Months Ended

Sep. 30, 2026

Company's population of financial assets and liabilities subject to fair value measurements

The Company’s population of financial assets and liabilities subject to fair value measurements were as follows:


				Fair Value Measurements
	Condensed Consolidated Balance Sheets Classification			September 30, 2026
		Fair Value at		Using Fair Value Hierarchy
		September 30, 2026		Level 1		Level 2		Level 3
Noncontrolling interest put	Noncontrolling interest	$	16.1	$	—	$	16.1	$	—
Cross currency swaps	Other liabilities	$	241.0	$	—	$	241.0	$	—
Interest rate swaps	Other liabilities	$	71.9	$	—	$	71.9	$	—


Cash surrender value of life insurance policies	Other assets, net	$	108.5	$	—	$	108.5	$	—
Deferred compensation asset	Other assets, net	$	66.0	$	—	$	66.0	$	—
Deferred compensation liability	Other liabilities	$	165.6	$	—	$	165.6	$	—

Contingent consideration	Accrued expenses and other/Other liabilities	$	124.0	$	—	$	—	$	124.0


				Fair Value Measurements
	Condensed Consolidated Balance Sheets Classification			December 31, 2025
		Fair Value at		Using Fair Value Hierarchy
		December 31, 2025		Level 1		Level 2		Level 3
Noncontrolling interest put	Noncontrolling interest	$	16.9	$	—	$	16.9	$	—
Cross currency swaps	Other liabilities	$	274.0	$	—	$	274.0	$	—
Interest rate swaps	Other liabilities	$	52.7	$	—	$	52.7	$	—
Cash surrender value of life insurance policies	Other assets, net	$	99.6	$	—	$	99.6	$	—
Deferred compensation asset	Other assets, net	$	53.1	$	—	$	53.1	$	—
Deferred compensation liability	Other liabilities	$	150.5	$	—	$	150.5	$	—

Contingent consideration	Accrued expenses and other/Other liabilities	$	50.0	$	—	$	—	$	50.0

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation


Fair Value Measurement of Level 3 Liabilities:	Contingent Consideration
Balance at December 31, 2025	$	50.0
Additions from business acquisitions, excluding measurement period adjustments, and purchase of intangible assets	120.8
Cash payments	(32.9)
Other adjustments	(13.9)
Balance at September 30, 2026	$	124.0	(1)

(1)At September 30, 2026, $45.2 and $78.8 of contingent consideration is included within Accrued expenses and other and Other liabilities, respectively, in the Company’s Condensed Consolidated Balance Sheets.

Derivative Instruments, Gain (Loss) [Table Text Block]

The table below provides information regarding the location and amount of pretax (losses) gains of derivatives designated in net investment hedging relationships:


	Amounts Included In Other Comprehensive Loss
	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025

Cross currency swaps	$	27.8	$	8.7	$	33.0	$	(139.6)